May 5, 2020 / 1:37 AM / a month ago

BRIEF-MGC Pharmaceuticals Says Phase II Clinical Trial On COVID-19 Patients Commenced

May 5 (Reuters) - MGC Pharmaceuticals Ltd:

* MGC PHARMACEUTICALS - PHASE II CLINICAL TRIAL ON COVID-19 PATIENTS COMMENCED

* MGC PHARMACEUTICALS- DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE SAFETY & EFFICACY OF ARTEMIC IN PATIENTS DIAGNOSED WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below